BIOMAT Database Logo BIOMAT Database Logo

[Initiation of myasthentic reactions by means of d-penicillamine (author's transl1]. 1978

K Rosenberger, and H Winter, and A E Adams

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

K Rosenberger, and H Winter, and A E Adams
[Freeze-fracture autoradiography (author's transl1].
February 1978, Mikroskopie,
K Rosenberger, and H Winter, and A E Adams
[Ocular myasthenia caused by D-penicillamine (author's transl)].
March 1976, Klinische Monatsblatter fur Augenheilkunde,
K Rosenberger, and H Winter, and A E Adams
Selected adverse reactions of D-penicillamine.
January 1984, Clinical and investigative medicine. Medecine clinique et experimentale,
K Rosenberger, and H Winter, and A E Adams
[Inhibition of fibroblast cultures by D-penicillamine (author's transl)].
August 1974, Klinische Wochenschrift,
K Rosenberger, and H Winter, and A E Adams
[D-penicillamine in rheumatoid arthritis (author's transl)].
December 1975, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
K Rosenberger, and H Winter, and A E Adams
[Ultrastructural study of a polymyositis caused by D-penicillamine (author's transl)].
January 1980, Archives d'anatomie et de cytologie pathologiques,
K Rosenberger, and H Winter, and A E Adams
Adverse reactions to D-penicillamine after gold toxicity.
August 1980, British medical journal,
K Rosenberger, and H Winter, and A E Adams
Adverse reactions to D-penicillamine after fold toxicity.
August 1980, British medical journal,
K Rosenberger, and H Winter, and A E Adams
Adverse reactions to D-penicillamine after gold toxicity.
June 1980, British medical journal,
K Rosenberger, and H Winter, and A E Adams
Skin reactions of rats to levamisole and D-penicillamine.
January 1980, International archives of allergy and applied immunology,
Copied contents to your clipboard!